CVS Health Stock Forecast for 2023 - 2025 - 2030
Updated on 04/24/2024
CVS Health Stock Forecast and Price Target
CVS Health's most recent price target of $87.80 for 2024 was provided by four renowned analysts over the past few months, with an average prediction of $87.80. If this prediction is correct, CVS Health's stock could rise by 28.18 percent from its current trading price. The potential increase for the stock is $87.80 per share, with a possible range of $76.00 to $103.00. If interested in CVS stock, you may also want to consider its competitors.
28.18% Upside
CVS Health Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, CVS Health's Price has decreased by 100.00%, from $70.05 to $0.00. In the next year, analysts predict that Fair Value will jump to $92.75 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that Fair Value will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AMZN Stock Forecast | Amazon.com Inc | Buy |
13
|
$179.54 | Buy/Sell | $204.68 | 19.19% |
| WMT Stock Forecast | Walmart Inc | Outperform |
15
|
$59.09 | Buy/Sell | $179.15 | 11.69% |
| UNH Stock Forecast | UnitedHealth Group | Buy |
16
|
$486.18 | Buy/Sell | $595.09 | 15.60% |
| MCD Stock Forecast | McDonald's Corp | Outperform |
15
|
$276.88 | Buy/Sell | $321.82 | 17.38% |
| SIE Stock Forecast | Siemens | Outperform |
10
|
175.34€ | Buy/Sell | 178.14€ | 11.50% |
CVS Health Revenue Forecast for 2023 - 2025 - 2030
In the last three years, CVS Health's Revenue has grown, moving from $267.91B to $356.62B – an increase of 33.11%. For the next year, 9 analysts project CVS Health's Revenue to drop by 5.56%, reaching $336.79B. Looking ahead to seven years, experts forecast that Revenue will grow by 9.18%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HON Stock Forecast | Honeywell International Inc | Outperform |
12
|
$196.16 | Buy/Sell | $219.12 | 13.43% |
| TJX Stock Forecast | TJX Cos Inc-The | Outperform |
17
|
$94.50 | Buy/Sell | $102.22 | 18.52% |
| MDT Stock Forecast | Medtronic | Outperform |
11
|
$81.29 | Buy/Sell | $92.47 | 17.48% |
.jpg)
CVS Health Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, CVS Health's Dividend per Share has seen an increase, rising from $2.00 to $2.42. This represents a growth of 21.00%. Analysts predict that CVS Health's Dividend per Share will increase in the upcoming year, reaching $2.48. This would represent an increase of 2.48%. Over the next seven years, experts predict that CVS Health's Dividend per Share will grow at a rate of 96.28%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CI Stock Forecast | The Cigna Group | Outperform |
12
|
$352.65 | Buy/Sell | $354.48 | 9.17% |
| HCA Stock Forecast | HCA Healthcare | Outperform |
18
|
$319.43 | Buy/Sell | $319.61 | 7.60% |
| TGT Stock Forecast | Target | Outperform |
13
|
$166.51 | Buy/Sell | $153.05 | 14.11% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| KR Stock Forecast | Kroger Co-The | Outperform |
12
|
$55.63 | Buy/Sell | $50.78 | 4.26% |
| CNC Stock Forecast | Centene | Outperform |
11
|
$75.84 | Buy/Sell | $88.33 | 18.67% |
| HUM Stock Forecast | Humana | Outperform |
14
|
$327.98 | Buy/Sell | $426.74 | 17.39% |
CVS Health EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, EBITDA for CVS Health has grown by 1.85%, going from $18.10B to $18.44B. In the coming year, analysts are expecting an increase in EBITDA, predicting it will reach $21.65B – an increase of 17.42%. Over the next seven years, experts anticipate that EBITDA growth for CVS Health will be 19.21%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DG Stock Forecast | Dollar General Corp | Outperform |
18
|
$142.73 | Buy/Sell | $142.39 | 10.70% |
| AD Stock Forecast | Koninklijke Ahold Delhaize N.V... | Hold |
18
|
27.88€ | Buy/Sell | 31.70€ | 7.60% |
| DLTR Stock Forecast | Dollar Tree Inc | Outperform |
15
|
$122.56 | Buy/Sell | $150.25 | 24.02% |
CVS Health EBIT Forecast for 2023 - 2025 - 2030
CVS Health's EBIT has grown in the last three years, jumping from $13.66B to $14.07B – an increase of 3.00%. In the next year, analysts predict that EBIT will reach $19.44B – an increase of 38.14%. For the next seven years, the forecast is for EBIT to grow by 56.71%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MOH Stock Forecast | Molina Healthcare | Outperform |
16
|
$363.22 | Buy/Sell | $393.38 | 15.18% |
| 6752 Stock Forecast | Panasonic Holdings | Outperform |
17
|
¥1.42k | Buy/Sell | ¥1.91k | 38.51% |
| WSM Stock Forecast | Williams-Sonoma | Hold |
16
|
$285.07 | Buy/Sell | $176.47 | 2.96% |
CVS Health EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, CVS Health's EPS has decreased by 100.00%, from $7.50 to $0.00. In the next year, analysts predict that EPS will jump to $9.93 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that EPS will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| WBA Stock Forecast | Walgreens Boots Alliance Inc | Hold |
11
|
$18.05 | Buy/Sell | $26.06 | 21.88% |
| UHS Stock Forecast | Universal Health Services | Outperform |
6
|
$164.91 | Buy/Sell | $162.38 | 13.40% |
| THC Stock Forecast | Tenet Healthcare | Outperform |
15
|
$97.86 | Buy/Sell | $86.63 | 15.47% |
.jpg)